Lung Neuroendocrine Carcinoma
NCI Definition: A high grade malignant neoplasm that arises from the lung and is characterized by the presence of malignant neuroendocrine cells. This category includes small cell lung carcinoma, large cell lung neuroendocrine carcinoma, and combined lung carcinoma. 
There is 1 clinical trial for lung neuroendocrine carcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains lung neuroendocrine carcinoma as an inclusion criterion, 1 is phase 2 (1 open).
Lenvatinib and pembrolizumab are the most common interventions in lung neuroendocrine carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.